Boston Millennia benefits from sale of biotech firm

November 4, 2009 12:44 PM E-mail| |Comments ()| Text size – +

Boston Millennia Partners, a private equity firm, said that one of its portfolio companies, Athenix Corp., has been acquired by Bayer CropScience for $400 million.

According to Boston Millennia Partners, the sale generated a tenfold return on the firm's investment in Athenix, a North Carolina-based biotechnology company that develops novel products and technologies for agricultural and industrial applications. (Globe Staff)